1 | DVBCWLQ1 ;ALB/JAM LIVER, GALL BLADDER AND PANCREAS WKS TEXT - 1 ; 19 FEBRUARY 1999
|
---|
2 | ;;2.7;AMIE;**36**;Apr 10, 1995
|
---|
3 | ;
|
---|
4 | ;
|
---|
5 | TXT ;
|
---|
6 | ;;
|
---|
7 | ;;A. Review of Medical Records: This may be of particular importance when
|
---|
8 | ;;hepatitis C (HCV) or chronic liver disease is claimed as related to service.
|
---|
9 | ;;
|
---|
10 | ;;
|
---|
11 | ;;B. Medical History (Subjective Complaints):
|
---|
12 | ;;
|
---|
13 | ;;Comment on:
|
---|
14 | ;; 1. Vomiting, hematemesis, or melena.
|
---|
15 | ;; 2. Current treatment-type (medication, diet, enzymes, etc.), duration,
|
---|
16 | ;; response, side effects.
|
---|
17 | ;; 3. Episodes of colic or other abdominal pain, fever, distention, nausea, or
|
---|
18 | ;; vomiting. Describe the duration, frequency, severity, treatment, and
|
---|
19 | ;; response to treatment.
|
---|
20 | ;; 4. Fatigue, weakness, depression, or anxiety, and their severity.
|
---|
21 | ;; 5. Past biliary tract surgery.
|
---|
22 | ;; 6. When chronic liver disease is claimed:
|
---|
23 | ;; * Record history of and dates for any risk factors for liver disease,
|
---|
24 | ;; including transfusion or organ transplant before 1992, hemodialysis,
|
---|
25 | ;; tattoo, body piercing, intravenous (or intranasal cocaine) drug use,
|
---|
26 | ;; occupational blood exposure or other percutaneous blood exposure,
|
---|
27 | ;; high-risk sexual activity, etc. Intramuscular gamma globulin shots
|
---|
28 | ;; may be claimed as a risk factor for hepatitis C, but, to date, no
|
---|
29 | ;; transmission of HCV by this means has been shown.
|
---|
30 | ;; * Describe current symptoms of liver disease and onset of symptoms.
|
---|
31 | ;; * Provide history of any hepatitis in service and discuss its
|
---|
32 | ;; relationship to current liver disease.
|
---|
33 | ;; * Provide history of alcohol use/abuse, both current and past.
|
---|
34 | ;;
|
---|
35 | ;;
|
---|
36 | ;;C. Physical Examination (Objective Findings):
|
---|
37 | ;;
|
---|
38 | ;;Address each of the following as appropriate, and fully describe
|
---|
39 | ;;current findings:
|
---|
40 | ;; 1. Ascites.
|
---|
41 | ;; 2. Weight gain or loss, steatorrhea, malabsorption, malnutrition.
|
---|
42 | ;; 3. Hematemesis or melena (describe any episodes).
|
---|
43 | ;; 4. Pain or tenderness-location, type, precipitating factors.
|
---|
44 | ;; 5. Liver size, superficial abdominal veins.
|
---|
45 | ;; 6. Muscle strength and wasting.
|
---|
46 | ;; 7. Any other signs of liver disease, e.g., palmar erythema,
|
---|
47 | ;; spider angiomata, etc.
|
---|
48 | ;;TOF
|
---|
49 | ;;D. Diagnostic and Clinical Tests:
|
---|
50 | ;;
|
---|
51 | ;; 1. For esophageal varices, X-ray, endoscopy, etc.
|
---|
52 | ;; 2. For adhesions, X-ray to show partial obstruction, delayed motility.
|
---|
53 | ;; 3. For gall bladder disease, X-ray or other objective confirmation.
|
---|
54 | ;; 4. For liver disease:
|
---|
55 | ;; * Liver function tests (albumin, prothrombin time, bilirubin, AST,
|
---|
56 | ;; ALT, WBC, platelets).
|
---|
57 | ;; * Serologic tests for hepatitis (HBsAg, anti-HCV (EIA or ELISA) anti-
|
---|
58 | ;; HBc, ferritin, alpha-fetoprotein); and liver imaging (ultrasound or
|
---|
59 | ;; abdominal CT scan), as appropriate.
|
---|
60 | ;; * If hepatitis C is the suspected diagnosis, a positive EIA (enzyme
|
---|
61 | ;; immunoassay) test for hepatitis C should be confirmed by a RIBA
|
---|
62 | ;; (recombinant immunoblot assay) test OR by an HCV RNA test,
|
---|
63 | ;; either qualitative or quantitative. The diagnosis of hepatitis
|
---|
64 | ;; C infection should not be made unless such test results are
|
---|
65 | ;; in the record and support the diagnosis. A positive EIA test alone
|
---|
66 | ;; is not sufficient to establish the diagnosis, nor is a liver biopsy
|
---|
67 | ;; with a report that indicates it is "consistent with"
|
---|
68 | ;; hepatitis C infection.
|
---|
69 | ;; * With a diagnosis of hepatitis, name the specific type (A, B, C, or
|
---|
70 | ;; other), and for hepatitis B and C, provide an opinion as to which risk
|
---|
71 | ;; factor is the most likely cause. Support the opinion by discussing all
|
---|
72 | ;; risk factors in the individual and the rationale for your opinion. If
|
---|
73 | ;; you can not determine which risk factor is the likely cause, state that
|
---|
74 | ;; there is no risk factor that is more likely than another
|
---|
75 | ;; to be the cause, and explain.
|
---|
76 | ;; * With a diagnosis of cirrhosis, chronic hepatitis, liver malignancy, or
|
---|
77 | ;; other chronic liver disease, state the most likely etiology and the
|
---|
78 | ;; basis for your opinion. Address the relationship of the disease to
|
---|
79 | ;; active service, including any hepatitis or hepatitis risk factor that
|
---|
80 | ;; occurred in service. If you cannot determine the most likely
|
---|
81 | ;; etiology, cannot determine whether it is more likely than not that one
|
---|
82 | ;; of multiple risk factors is the cause, or cannot determine whether it
|
---|
83 | ;; is at least as likely as not that the liver disease is related
|
---|
84 | ;; to service, so state and explain.
|
---|
85 | ;; 5. Include results of all diagnostic and clinical tests conducted in the
|
---|
86 | ;; examination report.
|
---|
87 | ;;
|
---|
88 | ;;
|
---|
89 | ;;E. Diagnosis:
|
---|
90 | ;;
|
---|
91 | ;;
|
---|
92 | ;;Signature: Date:
|
---|
93 | ;;END
|
---|